Stock Screener
Stock Research
Delisted Stocks
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Regeneron Pharmaceuticals Operating Income 2010-2023 | REGN

Regeneron Pharmaceuticals annual/quarterly operating income history and growth rate from 2010 to 2023. Operating income can be defined as income after operating expenses have been deducted and before interest payments and taxes have been deducted.
  • Regeneron Pharmaceuticals operating income for the quarter ending December 31, 2023 was $0.973B, a 15.16% decline year-over-year.
  • Regeneron Pharmaceuticals operating income for the twelve months ending December 31, 2023 was $4.047B, a 14.6% decline year-over-year.
  • Regeneron Pharmaceuticals annual operating income for 2023 was $4.047B, a 14.6% decline from 2022.
  • Regeneron Pharmaceuticals annual operating income for 2022 was $4.739B, a 47.03% decline from 2021.
  • Regeneron Pharmaceuticals annual operating income for 2021 was $8.947B, a 150.15% increase from 2020.
  
Regeneron Pharmaceuticals Annual Operating Income
(Millions of US $)
2023 $4,047
2022 $4,739
2021 $8,947
2020 $3,577
2019 $2,210
2018 $2,534
2017 $2,080
2016 $1,331
2015 $1,252
2014 $824
2013 $743
2012 $458
2011 $-205
2010 $-97
2009 $-74
Regeneron Pharmaceuticals Quarterly Operating Income
(Millions of US $)
2023-12-31 $973
2023-09-30 $1,111
2023-06-30 $1,017
2023-03-31 $947
2022-12-31 $1,147
2022-09-30 $1,224
2022-06-30 $1,110
2022-03-31 $1,259
2021-12-31 $2,640
2021-09-30 $1,847
2021-06-30 $3,347
2021-03-31 $1,113
2020-12-31 $1,167
2020-09-30 $1,053
2020-06-30 $656
2020-03-31 $700
2019-12-31 $676
2019-09-30 $739
2019-06-30 $316
2019-03-31 $480
2018-12-31 $718
2018-09-30 $627
2018-06-30 $622
2018-03-31 $567
2017-12-31 $539
2017-09-30 $560
2017-06-30 $550
2017-03-31 $431
2016-12-31 $347
2016-09-30 $363
2016-06-30 $292
2016-03-31 $329
2015-12-31 $231
2015-09-30 $392
2015-06-30 $345
2015-03-31 $284
2014-12-31 $216
2014-09-30 $188
2014-06-30 $228
2014-03-31 $192
2013-12-31 $195
2013-09-30 $237
2013-06-30 $158
2013-03-31 $153
2012-12-31 $146
2012-09-30 $202
2012-06-30 $87
2012-03-31 $22
2011-12-31 $-45
2011-09-30 $-58
2011-06-30 $-60
2011-03-31 $-41
2010-12-31 $-13
2010-09-30 $-32
2010-06-30 $-24
2010-03-31 $-29
2009-12-31 $-39
2009-09-30 $-1
2009-06-30 $-16
2009-03-31 $-17
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $96.942B $13.117B
Regeneron is a biotechnology company focused on the discovery, development and commercialization of treatments targeting serious medical conditions. The company's portfolio boasts nine marketed drugs - Eylea, Dupixent, Praluent, Kevzara, Libtayo, Evkeeza, Inmazeb Arcalyst and Zaltrap. The company also developed an antibody cocktail for COVID-19, REGEN-COV. REGEN-COV is a cocktail of two monoclonal antibodies and was designed specifically to block the infectivity of SARS-CoV-2, the virus that causes COVID-19. Regeneron has a collaboration agreement with Roche for the same. While Regeneron has co-developed Eylea with Bayer's HealthCare unit, Praluent was co-developed with Sanofi. Regeneron collaborated with Bayer for the joint development and commercialization of co-formulated combinations of Eylea, rinucumab and nesvacumab for the treatment of ocular diseases or disorders outside the United States.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $144.811B 14.48
Vertex Pharmaceuticals (VRTX) United States $102.732B 29.57
Bristol Myers Squibb (BMY) United States $90.900B 42.71
CSL (CSLLY) Australia $86.599B 0.00
GSK (GSK) United Kingdom $85.198B 10.68
Gilead Sciences (GILD) United States $81.453B 16.23
Moderna (MRNA) United States $41.340B 0.00
Biogen (BIIB) United States $30.415B 13.93
Argenex SE (ARGX) Netherlands $22.156B 0.00
BioNTech SE (BNTX) Germany $20.732B 21.17
Illumina (ILMN) United States $19.474B 140.55
Genmab (GMAB) Denmark $18.614B 23.86
Alnylam Pharmaceuticals (ALNY) United States $18.049B 0.00
BioMarin Pharmaceutical (BMRN) United States $15.270B 59.93
BeiGene (BGNE) Cayman Islands $14.688B 0.00
Sarepta Therapeutics (SRPT) United States $12.170B 0.00
Incyte (INCY) United States $11.604B 19.28
Exact Sciences (EXAS) United States $10.683B 0.00
Bio-Techne Corp (TECH) United States $10.070B 37.46
QIAGEN (QGEN) Netherlands $9.505B 19.67
Repligen (RGEN) United States $9.302B 96.29
Roivant Sciences (ROIV) United Kingdom $8.888B 0.00
Legend Biotech (LEGN) United States $8.241B 0.00
Viking Therapeutics (VKTX) United States $8.190B 0.00
Bio-Rad Laboratories (BIO.B) United States $7.982B 23.78
Ascendis Pharma (ASND) Denmark $7.913B 0.00
Intra-Cellular Therapies (ITCI) United States $7.092B 0.00
Exelixis (EXEL) United States $6.987B 37.03
Cytokinetics (CYTK) United States $6.833B 0.00
Vaxcyte (PCVX) United States $6.604B 0.00
Apellis Pharmaceuticals (APLS) United States $6.012B 0.00
Blueprint Medicines (BPMC) United States $5.692B 0.00
ImmunityBio (IBRX) United States $4.976B 0.00
Halozyme Therapeutics (HALO) United States $4.900B 15.13
CRISPR Therapeutics AG (CRSP) Switzerland $4.576B 0.00
Krystal Biotech (KRYS) United States $4.473B 0.00
Zealand Pharma (ZLDPF) Denmark $4.470B 0.00
Nuvalent (NUVL) United States $4.284B 0.00
Alkermes (ALKS) Ireland $4.175B 22.04
Immunovant (IMVT) United States $3.948B 0.00
Insmed (INSM) United States $3.684B 0.00
Ultragenyx Pharmaceutical (RARE) United States $3.641B 0.00
Biohaven (BHVN) United States $3.439B 0.00
Axsome Therapeutics (AXSM) United States $3.397B 0.00
SpringWorks Therapeutics (SWTX) United States $3.360B 0.00
Iovance Biotherapeutics (IOVA) United States $3.251B 0.00
Fortrea Holdings (FTRE) United States $3.249B 0.00
HUTCHMED (China) (HCM) Hong Kong, SAR China $3.164B 0.00
Xenon Pharmaceuticals (XENE) Canada $3.055B 0.00
Amicus Therapeutics (FOLD) United States $3.045B 0.00
IDEAYA Biosciences (IDYA) United States $2.986B 0.00
Immunocore Holdings (IMCR) United Kingdom $2.913B 0.00
Arcellx (ACLX) United States $2.767B 0.00
ACADIA Pharmaceuticals (ACAD) United States $2.753B 0.00
CG Oncology (CGON) United States $2.732B 0.00
MorphoSys AG (MOR) Germany $2.717B 0.00
MoonLake Immunotherapeutics (MLTX) Switzerland $2.715B 0.00
Certara (CERT) United States $2.654B 57.14
Merus (MRUS) Netherlands $2.643B 0.00
Janux Therapeutics (JANX) United States $2.448B 0.00
Rhythm Pharmaceuticals (RYTM) United States $2.302B 0.00
Vericel (VCEL) United States $2.228B 0.00
Arvinas (ARVN) United States $2.211B 0.00
Denali Therapeutics (DNLI) United States $2.199B 0.00
Vera Therapeutics (VERA) United States $2.159B 0.00
Guardant Health (GH) United States $2.112B 0.00
Keros Therapeutics (KROS) United States $2.087B 0.00
Geron (GERN) United States $2.073B 0.00
Kymera Therapeutics (KYMR) United States $2.048B 0.00
Celldex Therapeutics (CLDX) United States $2.029B 0.00
Apogee Therapeutics (APGE) United States $2.023B 0.00
Intellia Therapeutics (NTLA) United States $2.002B 0.00
Rocket Pharmaceuticals (RCKT) United States $1.989B 0.00
Avidity Biosciences (RNA) United States $1.942B 0.00
Sana Biotechnology (SANA) United States $1.922B 0.00
Galapagos (GLPG) Belgium $1.895B 0.00
Ginkgo Bioworks Holdings (DNA) United States $1.851B 0.00
Twist Bioscience (TWST) United States $1.824B 0.00
Structure Therapeutics (GPCR) United States $1.815B 0.00
NeoGenomics (NEO) United States $1.805B 0.00
Syndax Pharmaceuticals (SNDX) United States $1.789B 0.00
Beam Therapeutics (BEAM) United States $1.760B 0.00
Harmony Biosciences Holdings (HRMY) United States $1.665B 13.83
Bavarian Nordic (BVNRY) Denmark $1.651B 5.42
Myriad Genetics (MYGN) United States $1.645B 0.00
Inhibrx (INBX) United States $1.614B 0.00
Zai Lab (ZLAB) China $1.578B 0.00
Edgewise Therapeutics (EWTX) United States $1.506B 0.00
Kura Oncology (KURA) United States $1.497B 0.00
ADMA Biologics Inc (ADMA) United States $1.495B 0.00
Dynavax Technologies (DVAX) United States $1.467B 0.00
Protagonist Therapeutics (PTGX) United States $1.466B 0.00
Gyre Therapeutics (GYRE) United States $1.462B 0.00
Neumora Therapeutics (NMRA) United States $1.454B 0.00
Arcus Biosciences (RCUS) United States $1.414B 0.00
Morphic Holding (MORF) United States $1.405B 0.00
ANI Pharmaceuticals (ANIP) United States $1.378B 16.93
Akero Therapeutics (AKRO) United States $1.365B 0.00
Day One Biopharmaceuticals (DAWN) United States $1.304B 0.00
Kiniksa Pharmaceuticals (KNSA) Bermuda $1.263B 0.00
Verona Pharma American Depositary Share (VRNA) United Kingdom $1.250B 0.00
Ligand Pharmaceuticals (LGND) United States $1.249B 15.48
Spyre Therapeutics (SYRE) United States $1.213B 0.00
Deciphera Pharmaceuticals (DCPH) United States $1.184B 0.00
Belite Bio (BLTE) United States $1.159B 0.00
Mirum Pharmaceuticals (MIRM) United States $1.153B 0.00
MannKind (MNKD) United States $1.145B 0.00
Scholar Rock Holding (SRRK) United States $1.131B 0.00
Prothena (PRTA) Ireland $1.121B 0.00
Vir Biotechnology (VIR) United States $1.107B 0.00
AbCellera Biologics (ABCL) Canada $1.101B 0.00
Tarsus Pharmaceuticals (TARS) United States $1.096B 0.00
Cullinan Therapeutics (CGEM) United States $1.090B 0.00
Autolus Therapeutics (AUTL) United Kingdom $1.064B 0.00
Abivax SA (ABVX) France $0.993B 0.00
Liquidia Technologies (LQDA) United States $0.953B 0.00
MiMedx (MDXG) United States $0.925B 209.00
Immatics (IMTX) Germany $0.847B 0.00
ALX Oncology Holdings (ALXO) United States $0.843B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.835B 0.00
Tyra Biosciences (TYRA) United States $0.823B 0.00
Arcutis Biotherapeutics (ARQT) United States $0.820B 0.00
Immunome (IMNM) United States $0.820B 0.00
Viridian Therapeutics (VRDN) United States $0.808B 0.00
Tango Therapeutics (TNGX) United States $0.794B 0.00
REGENXBIO (RGNX) United States $0.794B 0.00
89BIO (ETNB) United States $0.787B 0.00
Zentalis Pharmaceuticals (ZNTL) United States $0.785B 0.00
PureTech Health (PRTC) United States $0.769B 0.00
Cytek Biosciences (CTKB) United States $0.754B 0.00
CARGO Therapeutics (CRGX) United States $0.735B 0.00
Praxis Precision Medicines (PRAX) United States $0.725B 0.00
Arcturus Therapeutics Holdings (ARCT) United States $0.715B 0.00
Pliant Therapeutics (PLRX) United States $0.712B 0.00
Mesoblast (MESO) Australia $0.712B 0.00
Longboard Pharmaceuticals (LBPH) United States $0.710B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.683B 0.00
EnGene Holdings (ENGN) United States $0.676B 0.00
Kyverna Therapeutics (KYTX) United States $0.667B 0.00
Disc Medicine (IRON) United States $0.665B 0.00
Pharming Group (PHAR) Netherlands $0.658B 0.00
Stoke Therapeutics (STOK) United States $0.647B 0.00
Y-mAbs Therapeutics (YMAB) United States $0.644B 0.00
HilleVax (HLVX) United States $0.636B 0.00
Dianthus Therapeutics (DNTH) United States $0.631B 0.00
Pharming Group (PHGUF) Netherlands $0.622B 0.00
Nurix Therapeutics (NRIX) United States $0.608B 0.00
Aerovate Therapeutics (AVTE) United States $0.606B 0.00
Mind Medicine (MindMed) (MNMD) United States $0.599B 0.00
Mineralys Therapeutics (MLYS) United States $0.589B 0.00
Nuvation Bio (NUVB) United States $0.584B 0.00
Northwest Biotherapeutics (NWBO) United States $0.584B 0.00
Zymeworks (ZYME) United States $0.583B 0.00
Cogent Biosciences (COGT) United States $0.576B 0.00
AnaptysBio (ANAB) United States $0.574B 0.00
Novavax (NVAX) United States $0.572B 0.00
WAVE Life Sciences (WVE) Singapore $0.570B 0.00
Castle Biosciences (CSTL) United States $0.558B 0.00
Olema Pharmaceuticals (OLMA) United States $0.556B 0.00
IGM Biosciences (IGMS) United States $0.553B 0.00
GH Research (GHRS) Ireland $0.547B 0.00
Oric Pharmaceuticals (ORIC) United States $0.544B 0.00
Phathom Pharmaceuticals (PHAT) United States $0.537B 0.00
Prime Medicine (PRME) United States $0.531B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.527B 0.00
CureVac (CVAC) Germany $0.522B 0.00
Absci (ABSI) United States $0.518B 0.00
ArriVent BioPharma (AVBP) United States $0.517B 0.00
Cabaletta Bio (CABA) United States $0.515B 0.00
Adlai Nortye (ANL) Cayman Islands $0.507B 0.00
Shattuck Labs (STTK) United States $0.504B 0.00
Alector (ALEC) United States $0.503B 0.00
Astria Therapeutics (ATXS) United States $0.494B 0.00
Allogene Therapeutics (ALLO) United States $0.493B 0.00
Arbutus Biopharma (ABUS) United States $0.490B 0.00
Applied Therapeutics (APLT) United States $0.489B 0.00
Oculis Holding AG (OCS) Switzerland $0.487B 0.00
Celcuity (CELC) United States $0.485B 0.00
Humacyte (HUMA) United States $0.475B 0.00
Avid Bioservices (CDMO) United States $0.467B 0.00
Fulcrum Therapeutics (FULC) United States $0.444B 0.00
Third Harmonic Bio (THRD) United States $0.441B 0.00
Editas Medicine (EDIT) United States $0.437B 0.00
Fate Therapeutics (FATE) United States $0.433B 0.00
C4 Therapeutics (CCCC) United States $0.423B 0.00
Annexon (ANNX) United States $0.423B 0.00
ACELYRIN, INC (SLRN) United States $0.419B 0.00
Entrada Therapeutics (TRDA) United States $0.418B 0.00
Voyager Therapeutics (VYGR) United States $0.414B 2.47
Travere Therapeutics (TVTX) United States $0.400B 0.00
Replimune (REPL) United States $0.394B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.389B 0.00
MaxCyte (MXCT) United States $0.387B 0.00
ITeos Therapeutics (ITOS) United States $0.387B 0.00
Biomea Fusion (BMEA) United States $0.387B 0.00
PepGen (PEPG) United States $0.386B 0.00
Neurogene (NGNE) United States $0.385B 0.00
Alto Neuroscience (ANRO) United States $0.381B 0.00
Anika Therapeutics (ANIK) United States $0.380B 0.00
Adaptive Biotechnologies (ADPT) United States $0.377B 0.00
ADC Therapeutics SA (ADCT) Switzerland $0.359B 0.00
Amarin (AMRN) Ireland $0.359B 0.00
Aura Biosciences (AURA) United States $0.357B 0.00
Mersana Therapeutics (MRSN) United States $0.357B 0.00
Revance Therapeutics (RVNC) United States $0.354B 0.00
Precigen (PGEN) United States $0.351B 0.00
TScan Therapeutics (TCRX) United States $0.351B 0.00
MEREO BIOPHARMA (MREO) United Kingdom $0.342B 0.00
Solid Biosciences (SLDB) United States $0.340B 0.00
Nkarta (NKTX) United States $0.339B 0.00
Tenaya Therapeutics (TNYA) United States $0.338B 0.00
Caribou Biosciences (CRBU) United States $0.335B 0.00
Rani Therapeutics Holdings (RANI) United States $0.335B 0.00
Urogen Pharma (URGN) United States $0.332B 0.00
FibroBiologics (FBLG) United States $0.330B 0.00
Ocugen (OCGN) United States $0.329B 0.00
Terns Pharmaceuticals (TERN) United States $0.317B 0.00
Atea Pharmaceuticals (AVIR) United States $0.312B 0.00
Nautilus Biotechnology (NAUT) United States $0.311B 0.00
MeiraGTx Holdings (MGTX) United States $0.308B 0.00
Jasper Therapeutics (JSPR) United States $0.307B 0.00
Kamada (KMDA) Israel $0.296B 22.39
XOMA (XOMA) United States $0.296B 0.00
Werewolf Therapeutics (HOWL) United States $0.293B 0.00
CorMedix Inc (CRMD) United States $0.291B 0.00
Contineum Therapeutics (CTNM) United States $0.287B 0.00
Erasca (ERAS) United States $0.286B 0.00
Anavex Life Sciences (AVXL) United States $0.282B 0.00
Rapt Therapeutics (RAPT) United States $0.282B 0.00
Oxford BioMedica (OXBDF) United Kingdom $0.280B 0.00
Ventyx Biosciences (VTYX) United States $0.277B 0.00
Inozyme Pharma (INZY) United States $0.274B 0.00
Monte Rosa Therapeutics (GLUE) United States $0.267B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.266B 92.40
Adaptimmune Therapeutics (ADAP) United Kingdom $0.265B 0.00
ChromaDex (CDXC) United States $0.259B 0.00
Invivyd (IVVD) United States $0.256B 0.00
Inovio Pharmaceuticals (INO) United States $0.247B 0.00
Agenus (AGEN) United States $0.245B 0.00
Puma Biotechnology (PBYI) United States $0.242B 10.91
XBiotech (XBIT) United States $0.240B 0.00
Verastem (VSTM) United States $0.237B 0.00
Prima BioMed (IMMP) Australia $0.233B 0.00
AC Immune (ACIU) Switzerland $0.232B 0.00
Coherus BioSciences (CHRS) United States $0.232B 0.00
23andMe Holding (ME) United States $0.224B 0.00
Renovaro (RENB) United States $0.220B 0.00
Ovid Therapeutics (OVID) United States $0.220B 0.00
2seventy Bio (TSVT) United States $0.218B 0.00
UniQure (QURE) Netherlands $0.217B 0.00
Merrimack Pharmaceuticals (MACK) United States $0.214B 0.00
Design Therapeutics (DSGN) United States $0.214B 0.00
Sutro Biopharma (STRO) United States $0.214B 0.00
G1 Therapeutics (GTHX) United States $0.208B 0.00
Poseida Therapeutics (PSTX) United States $0.206B 0.00
INmune Bio (INMB) United States $0.206B 0.00
Lifecore Biomedical (LFCR) United States $0.200B 0.00
Compass Therapeutics (CMPX) United States $0.200B 0.00
Innate Pharma S.A (IPHA) France $0.199B 0.00
Opthea (OPT) Australia $0.199B 0.00
Annovis Bio (ANVS) United States $0.198B 0.00
X4 Pharmaceuticals (XFOR) United States $0.196B 0.00
Trevi Therapeutics (TRVI) United States $0.192B 0.00
Adverum Biotechnologies (ADVM) United States $0.191B 0.00
Acumen Pharmaceuticals (ABOS) United States $0.190B 0.00
Zura Bio (ZURA) United States $0.190B 0.00
Akoya Biosciences (AKYA) United States $0.188B 0.00
Candel Therapeutics (CADL) United States $0.188B 0.00
Codexis (CDXS) United States $0.187B 0.00
Alimera Sciences (ALIM) United States $0.183B 0.00
Cardiff Oncology (CRDF) United States $0.182B 0.00
Elevation Oncology (ELEV) United States $0.176B 0.00
GENFIT S.A (GNFT) France $0.174B 0.00
Kodiak Sciences (KOD) United States $0.172B 0.00
Inventiva S.A (IVA) France $0.171B 0.00
Greenwich LifeSciences (GLSI) United States $0.169B 0.00
Adocia (ADOCY) France $0.169B 0.00
Compugen (CGEN) Israel $0.166B 0.00
ScPharmaceuticals (SCPH) United States $0.162B 0.00
Skye Bioscience (SKYE) United States $0.161B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.158B 0.00
Orchestra BioMed Holdings (OBIO) United States $0.157B 0.00
Gossamer Bio (GOSS) United States $0.151B 0.00
BioStem Technologies (BSEM) $0.148B 0.00
CervoMed (CRVO) United States $0.147B 0.00
Scilex Holding (SCLX) United States $0.146B 0.00
I-Mab (IMAB) China $0.145B 0.00
Molecular Partners AG (MOLN) Switzerland $0.141B 0.00
Cellectis S.A (CLLS) France $0.139B 0.00
Adicet Bio (ACET) United States $0.138B 0.00
Syros Pharmaceuticals (SYRS) United States $0.135B 0.00
DBV Technologies S.A (DBVT) France $0.132B 0.00
Sagimet Biosciences (SGMT) United States $0.130B 0.00
VistaGen Therapeutics (VTGN) United States $0.128B 0.00
Coya Therapeutics (COYA) United States $0.126B 0.00
Omega Therapeutics (OMGA) United States $0.125B 0.00
Seres Therapeutics (MCRB) United States $0.125B 0.00
Seer (SEER) United States $0.124B 0.00
BioAtla (BCAB) United States $0.122B 0.00
PDS Biotechnology (PDSB) United States $0.120B 0.00
Repare Therapeutics (RPTX) Canada $0.118B 0.00
Nuvectis Pharma (NVCT) United States $0.116B 0.00
Vor Biopharma (VOR) $0.115B 0.00
Cartesian Therapeutics (RNAC) United States $0.113B 0.00
Immunic (IMUX) United States $0.110B 0.00
TELA Bio (TELA) United States $0.110B 0.00
Oncobiologics (OTLK) United States $0.110B 0.00
CytomX Therapeutics (CTMX) United States $0.108B 0.00
Sangamo Therapeutics (SGMO) United States $0.107B 0.00
Rezolute (RZLT) United States $0.107B 0.00
ATyr Pharma (LIFE) United States $0.107B 0.00
Adagene (ADAG) China $0.105B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.103B 0.00
BioHarvest Sciences (CNVCF) Canada $0.102B 0.00
Vigil Neuroscience (VIGL) United States $0.102B 0.00
Bluebird Bio (BLUE) United States $0.101B 0.00
Emergent Biosolutions (EBS) United States $0.101B 0.00
Clearside Biomedical (CLSD) United States $0.100B 0.00
DiaMedica Therapeutics (DMAC) United States $0.098B 0.00
BioXcel Therapeutics (BTAI) United States $0.097B 0.00
Barinthus Biotherapeutics (BRNS) United Kingdom $0.097B 0.00
IO Biotech (IOBT) Denmark $0.094B 0.00
Elicio Therapeutics (ELTX) United States $0.092B 0.00
Genelux (GNLX) United States $0.091B 0.00
Q32 Bio (QTTB) United States $0.091B 0.00
Allakos (ALLK) United States $0.090B 0.00
Abeona Therapeutics (ABEO) United States $0.089B 0.00
Eton Pharmaceuticals (ETON) United States $0.089B 0.00
HOOKIPA Pharma (HOOK) United States $0.088B 0.00
Curis (CRIS) United States $0.085B 0.00
Aileron Therapeutics (ALRN) United States $0.085B 0.00
Provectus Biopharmaceuticals (PVCT) United States $0.083B 0.00
Leap Therapeutics (LPTX) United States $0.083B 0.00
BeyondSpring (BYSI) United States $0.083B 0.00
Atara Biotherapeutics (ATRA) United States $0.082B 0.00
Oncolytics Biotech (ONCY) Canada $0.082B 0.00
Galena Biopharma (SLS) United States $0.082B 0.00
Milestone Pharmaceuticals (MIST) Canada $0.082B 0.00
Passage Bio (PASG) United States $0.081B 0.00
VTv Therapeutics (VTVT) United States $0.081B 0.00
Gritstone Bio (GRTS) United States $0.080B 0.00
Spero Therapeutics (SPRO) United States $0.079B 2.92
InflaRx (IFRX) Germany $0.078B 0.00
Affimed (AFMD) Germany $0.077B 0.00
Eupraxia Pharmaceuticals (EPRX) $0.076B 0.00
Cognition Therapeutics (CGTX) United States $0.076B 0.00
YS Biopharma (YS) China $0.074B 0.00
Connect Biopharma Holdings (CNTB) United States $0.074B 0.00
Athira Pharma (ATHA) United States $0.074B 0.00
Corvus Pharmaceuticals (CRVS) United States $0.071B 0.00
Alpha Teknova (TKNO) United States $0.071B 0.00
Regencell Bioscience Holdings (RGC) Hong Kong, SAR China $0.070B 0.00
Landos Biopharma (LABP) United States $0.070B 0.00
Anebulo Pharmaceuticals (ANEB) United States $0.069B 0.00
AN2 Therapeutics (ANTX) United States $0.069B 0.00
Instil Bio (TIL) United States $0.069B 0.00
Elutia (ELUT) United States $0.067B 0.00
CollPlant Biotechnologies (CLGN) Israel $0.067B 0.00
Cue Biopharma (CUE) United States $0.066B 0.00
Precision BioSciences (DTIL) United States $0.065B 0.00
Rallybio (RLYB) United States $0.064B 0.00
MediciNova (MNOV) United States $0.064B 0.00
Turnstone Biologics (TSBX) United States $0.064B 0.00
Ikena Oncology (IKNA) United States $0.063B 0.00
Equillium (EQ) United States $0.060B 0.00
Kronos Bio (KRON) United States $0.060B 0.00
Aligos Therapeutics (ALGS) United States $0.059B 0.00
Lantern Pharma (LTRN) United States $0.059B 0.00
Kezar Life Sciences (KZR) United States $0.059B 0.00
CalciMedica (CALC) United States $0.059B 0.00
Celularity (CELU) United States $0.059B 0.00
Cidara Therapeutics (CDTX) United States $0.058B 0.00
LENZ Therapeutics (LENZ) United States $0.057B 0.00
Entera Bio (ENTX) Israel $0.057B 0.00
Immix Biopharma (IMMX) United States $0.056B 0.00
AVROBIO (AVRO) United States $0.054B 0.00
Intensity Therapeutics (INTS) United States $0.054B 0.00
Enzo Biochem (ENZ) United States $0.054B 0.00
HCW Biologics (HCWB) United States $0.053B 0.00
ARCA Biopharma (ABIO) United States $0.052B 0.00
Eledon Pharmaceuticals (ELDN) United States $0.051B 0.00
Checkpoint Therapeutics (CKPT) United States $0.051B 0.00
Genenta Science S.p.A (GNTA) Italy $0.047B 0.00
Ocean Biomedical (OCEA) United States $0.046B 0.00
Quince Therapeutics (QNCX) United States $0.046B 0.00
Clene (CLNN) United States $0.044B 0.00
Immuneering (IMRX) United States $0.044B 0.00
Dyadic (DYAI) United States $0.044B 0.00
Bionano Genomics (BNGO) United States $0.043B 0.00
Aadi Bioscience (AADI) United States $0.043B 0.00
OKYO Pharma (OKYO) $0.042B 0.00
Bolt Biotherapeutics (BOLT) United States $0.042B 0.00
Prenetics Global (PRE) Cayman Islands $0.042B 0.00
Beyond Air (XAIR) United States $0.042B 0.00
Apollomics (APLM) United States $0.040B 0.00
Carmell (CTCX) United States $0.040B 0.00
Ocuphire Pharma (OCUP) United States $0.040B 0.00
SAB Biotherapeutics (SABS) United States $0.039B 0.00
NextCure (NXTC) United States $0.038B 0.00
Xilio Therapeutics (XLO) United States $0.038B 0.00
Promis Neurosciences (PMN) Canada $0.038B 0.00
Cara Therapeutics (CARA) United States $0.037B 0.00
Estrella Immunopharma (ESLA) United States $0.037B 0.00
NKGen Biotech (NKGN) United States $0.037B 0.00
Brainstorm Cell Therapeutics (BCLI) United States $0.037B 0.00
Cyclo Therapeutics (CYTH) United States $0.036B 0.00
BRIACELL THERAP (BCTX) Canada $0.035B 0.00
IN8bio (INAB) United States $0.033B 0.00
Fortress Biotech (FBIO) United States $0.033B 0.00
Acurx Pharmaceuticals (ACXP) United States $0.033B 0.00
MiNK Therapeutics (INKT) United States $0.032B 0.00
Theratechnologies (THTX) Canada $0.031B 0.00
Dare Bioscience (DARE) United States $0.031B 0.00
Achilles Therapeutics (ACHL) United Kingdom $0.030B 0.00
Lexaria Bioscience (LEXX) Canada $0.030B 0.00
Eyenovia (EYEN) United States $0.030B 0.00
Spruce Biosciences (SPRB) United States $0.029B 0.00
Aprea Therapeutics (APRE) United States $0.028B 0.00
Femasys (FEMY) United States $0.028B 0.00
Pluri (PLUR) Israel $0.028B 0.00
BioAffinity Technologies (BIAF) United States $0.027B 0.00
Forte Biosciences (FBRX) United States $0.026B 0.00
Evogene (EVGN) Israel $0.026B 0.00
Sensei Biotherapeutics (SNSE) United States $0.026B 0.00
UNITY Biotechnology (UBX) United States $0.025B 0.00
CytoMed Therapeutics (GDTC) Singapore $0.023B 0.00
Biora Therapeutics (BIOR) United States $0.023B 0.00
Lumos Pharma (LUMO) United States $0.022B 0.00
Lisata Therapeutics (LSTA) United States $0.022B 0.00
Evaxion Biotech (EVAX) Denmark $0.022B 0.00
Synlogic (SYBX) United States $0.022B 0.00
RenovoRx (RNXT) United States $0.021B 0.00
Aptose Biosciences (APTO) Canada $0.019B 0.00
Galecto (GLTO) Denmark $0.019B 0.00
Benitec Biopharma (BNTC) United States $0.018B 0.00
KALA BIO (KALA) United States $0.018B 0.00
Orgenesis (ORGS) United States $0.017B 0.00
NeuroSense Therapeutics (NRSN) Israel $0.017B 0.00
Talis Biomedical (TLIS) United States $0.017B 0.00
VBI Vaccines (VBIV) United States $0.016B 0.00
Aytu BioPharma (AYTU) United States $0.016B 0.00
Cocrystal Pharma (COCP) United States $0.016B 0.00
Semper Paratus Acquisition (TVGN) United States $0.016B 0.00
Vincerx Pharma (VINC) United States $0.016B 0.00
NeuroBo Pharmaceuticals (NRBO) United States $0.015B 0.00
IMMURON (IMRN) Australia $0.015B 0.00
ABVC BioPharma (ABVC) United States $0.015B 0.00
Cardio Diagnostics Holdings (CDIO) United States $0.015B 0.00
Vaxxinity (VAXX) United States $0.015B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.014B 0.00
Edesa Biotech (EDSA) Canada $0.014B 0.00
Imunon (IMNN) United States $0.014B 0.00
Senti Biosciences (SNTI) United States $0.013B 0.00
MIRA Pharmaceuticals (MIRA) United States $0.013B 0.00
Purple Biotech (PPBT) Israel $0.012B 0.00
Coeptis Therapeutics Holdings (COEP) United States $0.012B 0.00
Prana Biotechnology (ATHE) Australia $0.012B 0.00
Monopar Therapeutics (MNPR) United States $0.011B 0.00
Elevai Labs (ELAB) United States $0.011B 0.00
Moleculin Biotech (MBRX) United States $0.010B 0.00
BioCardia (BCDA) United States $0.010B 0.00
Galera Therapeutics (GRTX) United States $0.010B 0.00
Organovo Holdings (ONVO) United States $0.010B 0.00
Eterna Therapeutics (ERNA) United States $0.010B 0.00
Telesis Bio (TBIO) United States $0.010B 0.00
AEterna Zentaris (AEZS) Canada $0.010B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.009B 0.00
Virios Therapeutics (VIRI) United States $0.009B 0.00
Genetic Technologies (GENE) Australia $0.009B 0.00
Biorestorative Therapies (BRTX) United States $0.008B 0.00
NuCana (NCNA) United Kingdom $0.008B 0.00
Bionomics (BNOX) Australia $0.008B 0.00
Biofrontera (BFRI) United States $0.008B 0.00
Cyclerion Therapeutics (CYCN) United States $0.008B 0.00
Psyence Biomedical (PBM) United States $0.008B 0.00
Pasithea Therapeutics (KTTA) United States $0.008B 0.00
AquaBounty Technologies (AQB) United States $0.008B 0.00
Hepion Pharmaceuticals (HEPA) United States $0.008B 0.00
Pulmatrix (PULM) United States $0.007B 0.00
TFF Pharmaceuticals (TFFP) United States $0.007B 0.00
Lixte Biotechnology Holdings (LIXT) United States $0.007B 0.00
Vaccinex (VCNX) United States $0.007B 0.00
Trevena (TRVN) United States $0.007B 0.00
Chemomab Therapeutics (CMMB) Israel $0.007B 0.00
EFFECTOR Therapeutics (EFTR) United States $0.007B 0.00
Cadrenal Therapeutics (CVKD) United States $0.007B 0.00
Tenax Therapeutics (TENX) United States $0.007B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.007B 0.00
Kineta (KA) United States $0.007B 0.00
Adial Pharmaceuticals (ADIL) United States $0.007B 0.00
Enveric Biosciences (ENVB) United States $0.007B 0.00
Titan Pharmaceuticals (TTNP) United States $0.006B 0.00
Atrinsic (PTIX) United States $0.006B 0.00
Novogen (KZIA) Australia $0.006B 0.00
Creative Medical Technology Holdings (CELZ) United States $0.006B 0.00
Kintara Therapeutics (KTRA) United States $0.006B 0.00
Hoth Therapeutics (HOTH) United States $0.006B 0.00
First Wave BioPharma (FWBI) United States $0.006B 0.00
PaxMedica (PXMD) United States $0.006B 0.00
Sonnet BioTherapeutics Holdings (SONN) United States $0.005B 0.00
Silo Pharma (SILO) United States $0.005B 0.00
Palisade Bio (PALI) United States $0.005B 0.00
Alzamend Neuro (ALZN) United States $0.005B 0.00
Synaptogenix (SNPX) United States $0.005B 0.00
Bright Minds Biosciences (DRUG) United States $0.005B 0.00
GT Biopharma (GTBP) United States $0.005B 0.00
NexImmune (NEXI) United States $0.005B 0.00
Lipella Pharmaceuticals (LIPO) United States $0.004B 0.00
Cingulate (CING) United States $0.004B 0.00
Longeveron (LGVN) United States $0.004B 0.00
Tharimmune (THAR) United States $0.004B 0.00
Exicure (XCUR) United States $0.004B 0.30
Artelo Biosciences (ARTL) United States $0.004B 0.00
Soligenix (SNGX) United States $0.004B 0.00
Ensysce Biosciences (ENSC) United States $0.004B 0.00
Portage Biotech (PRTG) $0.004B 0.00
GENPREX (GNPX) United States $0.004B 0.00
TRACON Pharmaceuticals (TCON) United States $0.004B 0.00
Seelos Therapeutics (SEEL) United States $0.004B 0.00
ZyVersa Therapeutics (ZVSA) United States $0.004B 0.00
Virpax Pharmaceuticals (VRPX) United States $0.004B 0.00
Revelation Biosciences (REVB) United States $0.004B 0.00
GeoVax Labs (GOVX) United States $0.003B 0.00
Mustang Bio (MBIO) United States $0.003B 0.00
Avalon GloboCare (ALBT) United States $0.003B 0.00
ARAVIVE, INC (ARAV) United States $0.003B 0.00
Allarity Therapeutics (ALLR) United States $0.003B 0.00
Invo BioScience (INVO) United States $0.003B 0.00
Onconetix (ONCO) United States $0.003B 0.00
CNS Pharmaceuticals (CNSP) United States $0.002B 0.00
Dermata Therapeutics (DRMA) United States $0.002B 0.00
Notable Labs (NTBL) United States $0.002B 0.00
ThermoGenesis Holdings (THMO) United States $0.002B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.002B 0.00
Biodexa Pharmaceuticals (BDRX) United Kingdom $0.002B 0.00
NeuBase Therapeutics (NBSE) United States $0.002B 0.00
180 Life Sciences (ATNF) United States $0.002B 0.00
Windtree Therapeutics (WINT) United States $0.002B 0.00
GRI Bio (GRI) United States $0.001B 0.00
Virax Biolabs Group (VRAX) United Kingdom $0.001B 0.00
TC BioPharm (Holdings) (TCBP) United Kingdom $0.001B 0.00
Sunshine Biopharma (SBFM) United States $0.001B 0.00
Scinai Immunotherapeutics (SCNI) Israel $0.001B 0.00
Bone Biologics (BBLG) United States $0.001B 0.00
Aptevo Therapeutics (APVO) United States $0.000B 0.00
Sinovac Biotech (SVA) China $0.000B 0.00
Aceragen (ACGN) United States $0.000B 0.00
Alvotech (ALVO) $0.000B 0.00
Celyad SA (CYAD) Belgium $0.000B 0.00
LAVA Therapeutics (LVTX) Netherlands $0.000B 0.00
Motif Bio Plc (MTFB) United Kingdom $0.000B 0.00
Mainz Biomed (MYNZ) Germany $0.000B 0.00
PDL BioPharma (PDLI) United States $0.000B 0.00
Pharvaris (PHVS) Netherlands $0.000B 0.00
Tiziana Life Sciences (TLSA) United Kingdom $0.000B 0.00
VectivBio Holding AG (VECT) Switzerland $0.000B 0.00
Clovis Oncology (CLVSQ) United States $0.000B 0.00